Recombinant HPV Vaccine Supply
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
AI Contract Overview
This subcontract with the Defense Logistics Agency under the Department of Defense involves the supply and delivery of 2,000 units of recombinant HPV vaccine. The deliverables must adhere to federal pharmaceutical standards, specifically complying with NSN/Part 6505016898408 and NDC 00006-4121-02, for shipment to a designated DLA destination. The procurement is categorized under NAICS code 325412 and was posted on August 10, 2026. All requirements are managed through the Defense Logistics Agency to ensure the delivery of medical supplies that meet strict regulatory and pharmaceutical specifications.
General Info
Agency
NAICS
Place of Performance
Not specifiedSet-Aside
Documents
This scope was carved out of SPEZD-26-F-3236.
The full solicitation package (2 documents), including the RFP, is on the prime solicitation, not on this scope.
HUMAN PAPILLOMAVIRUS VACCINE, RECOMBINANT
AI Contract Breakdown
Uniform Contract FormatNo contract breakdown available.
Cannot generate Contract Breakdown because no documents were found from this contract's source.
Timeline
Organization & Contact Information
Full Description
Similar Contracts
Same NAICS industry code
More opportunities from Department Of Defense → Defense Logistics Agency
Same awarding agency
Ready to Pursue This Opportunity?
Get AI-powered intelligence on this solicitation and the ones like it
Every page of the solicitation package shredded into a compliance breakdown
AI-powered matching based on your capabilities and past performance
Competitor and incumbent history on the requirement
Automated alerts on amendments, Q&A deadlines, and award
Join 650+ contractors already using CLEATUS
